CClinicalTrials.gg
RecruitingNCT07849907Updated Sep 30, 2026

The Parasite and Infestation Study

An observational study in Parasite and Infestation Physician-Patient Diagnostic Incongruency, sponsored by Vanderbilt University Medical Center. Recruiting at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by Vanderbilt University Medical Center · Observational

From the registry’s dates

  • Started Dec 2024; still recruiting 1 year 9 months later.
Updated Sep 30, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
25
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Many people have evidence of bugs, parasites, and infestation, but are told by others that they cannot find a cause. This distressing and frustrating experience can last for years, as the person seeks answers. The current study aims to understand the experience of these individuals. In a 1-2 hour session over Zoom, the investigators will ask participants questions about their experience, have them complete self-report questionnaires, and ask them to complete a few games on the computer. The investigators' goal is to help characterize and understand individuals with this experience to aid in better treatment and inform recommendations for providers.

Read the detailed description

The current study aims to characterize the experiences of people who have evidence of bugs, parasites, and/or infestation but are told by physicians or other professionals (e.g. vets, pest control) that there is nothing wrong. The investigators seek to understand the emotional and cognitive aspects of this experience, through semi-structured interviews, self-report questionnaires, and cognitive tasks. The study will take a few hours and is conducted remotely, allowing for participation regardless of the participant's physical location. There is practically no aggregate information on this experience, with most current information relying on case reports and medical record review. The investigators hope to provide greater insights into this experience to guide support for individuals going through this difficult process.

02

Conditions studied

  • Parasite and Infestation Physician-Patient Diagnostic Incongruency

Browse trials for

Keywords

  • parasites
  • infestation
  • Morgellons Disease
  • bugs crawling
  • tactile
03

In context

Parasitic Diseases

62 studies on the registry are indexed under Parasitic Diseases; 13 are open to participants now.

This study's planned enrollment of 25 is below the median of 219 across 21 observational studies indexed under Parasitic Diseases.

Browse Parasitic Diseases studies →

Lead sponsor

Vanderbilt University Medical Center is the lead sponsor of 824 studies on the registry; 164 are open to participants now.

Of its 122 completed or terminated interventional studies of FDA-regulated products, 91 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults with a persistent experience of infestation or parasite that physicians or other professionals report no evidence for.

Inclusion criteria

  • Men and women aged 18-70 years old
  • At least 50% certain that they have an active infection/infestation/parasite, despite being told by doctor that they do not
  • Ability to read and speak English
  • Access to a computer or phone for virtual visit
  • No self-reported history of schizophrenia-spectrum disorder

Exclusion criteria

Exclusion Criteria:

  • Active substance use disorder (excluding nicotine and caffeine)
  • History of severe head trauma
  • Current use of antipsychotics
  • Serious medical or neurological illness known to interfere with cognitive functioning
  • Diagnosis of a learning disability or cognitive disorder
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
25 participants (estimated)
Patient registry
No

Groups and cohorts

  • PPDI Group

    Other: No intervention - observational study

Interventions

  • OtherNo intervention - observational study

    This study will not involve an intervention.

06

What researchers measure

Primary outcomes

  1. Psychological Wellbeing

    Total score on the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS); scores range from 14-70; higher scores reflect greater wellbeing

    Time frame: Baseline

  2. Social Network

    Ludden Social Network Scale - total score; higher scores reflect larger and closer social network (score: 0-30)

    Time frame: Baseline

  3. Depression

    Total score - Beck Depression Inventory -II; Scores range from 0-63 with higher scores reflecting worse depression

    Time frame: Baseline

  4. Anxiety

    Perseverative Thinking Questionnaire (PTQ); scores range from 0-60, higher scores reflect more perseveration

    Time frame: Baseline

  5. Belief Updating

    Expectations of prior volatility (mu3) calculated from reversal learning task; higher parameter scores reflect greater expectations of volatility

    Time frame: Baseline

  6. BADE

    Evidence Integration Impairment (EII) will be calculated based on decisions on the Bias Against Disconfirmatory Evidence task. Higher scores reflect more difficulty integrating information

    Time frame: Baseline

  7. Interoceptive Awareness

    Multidimensional Assessment of Interoceptive Awareness-2; scores range from 0-185; higher scores reflect better interpersonal awareness

    Time frame: Baseline

  8. Dissociation

    Cernis Felt Sense of Anomaly Scale (CEFSA); scores range from 0-140, higher scores reflect more severe dissociative experiences

    Time frame: Baseline

  9. Childhood Trauma

    Childhood Trauma Questionnaire (CTQ)- scores range from 5-100, higher scores reflect more severe childhood maltreatment

    Time frame: Baseline

  10. DACOBS

    Davos Assessment of Cognitive Biases Scale; higher scores reflect more severe cognitive biases. Scores range from 42-294

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
  • Vanderbilt University Medical Center
    Nashville, Tennessee 37212, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Sep 30, 2026
Show all 1 update
  1. Sep 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07849907
Lead sponsor
Vanderbilt University Medical Center
Responsible party
Julia Sheffield (Assistant Professor, Vanderbilt University Medical Center) — Principal investigator
First posted
Sep 30, 2026
Start date
Dec 31, 2024
Primary completion
Dec 2029 (estimated)
Completion
Dec 2030 (estimated)
Last update
Sep 30, 2026

Study contacts

Sheffield Lab
Contact
sheffieldlab.vumc@gmail.com
(615) 686-2488
Julia Sheffield, PhD
principal investigator · Vanderbilt University Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion